Global Single Cell Analysis Market Overview:
According to SPER Market Research, the single cell analysis market is estimated to reach USD 10.57 billion by 2030 with a CAGR of 14.6%. Single cell analysis is the study of transcriptomics, genomics and other cellular interactions at a single cell level. The rising prevalence of cancer creates urgent need for better diagnostic models which can be served by single cell analysis.
Impact of COVID-19 on the Single Cell Analysis Market
The COVID-19 pandemic has prompted the development and manufacturing of vaccines. The government initiatives to meet the vaccine demand has increased the adoption of single-cell analysis product. Single-cell analysis technique assist the researchers to understand immune response on single-cell basis in order to evaluate prognosis of disease, identify diagnostic markers and develop therapeutic interventions.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Product, By Technology, By Application, By End User
|
| Geographies covered | North America, Europe, APAC, Latin America and the Middle East & Africa |
| Companies Covered | 10x Genomics, Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Corning Incorporated, Cytek Biosciences, Danaher Corporation, Fluidigm Corporation, Fluxion Biosciences, Illumina, Inc., Luminex Corporation, Menarini Silicon Biosystems, Inc., Merck KGAA, NanoCellect Biomedical, On-chip Biotechnologies Co., Ltd., Oxford Nanopore Technologies, Promega Corporation, QIAGEN N.V., Rarecyte Inc, Sartorius AG, Takara Bio, Tecan Group Ltd., Thermo Fisher Scientific, Inc.
|
Driver: Rising prevalence of Cancer
The prevalence of Cancer is increasing across the globe creating urgent need for extensive research and development for better diagnosis and therapeutic interventions. Single-cell analysis provides accurate diagnosis of cancer and enables early treatment. Single-cell analysis can be used in monitoring the progression of tumors.
Restraints: Budget constraints for expensive products
Single-cell analysis is an expensive technique as it requires to maintain quality standards and comply with the regulatory recommended guidelines. Additionally, maintenance and indirect costs also add up in total cost of ownership. Many academic laboratories can not afford such costly analytical instruments which restraints the growth of this market.
Opportunity: Growth potential in single cell sequencing
Single cell sequencing provides a powerful technology to identify biomarkers for the diagnosis of diseases and monitor the progression of disease as well as response of patient to the treatment. Due to the quality of analysis, there is a huge growth potential in this market. Thus, companies are focusing on advancement of more single cell sequencing instruments in the forecast period.
Single Cell Analysis Market Segmentation:
By Product: Based on product, market has been segmented into Consumables (Beads, Microplates, Reagents, Assay Kits [Immunoassays, Cell-based Assays], Other Consumables), Instruments (Flow Cytometers, NGS Systems, PCR Instruments, Spectrophotometers, Microscopes, Cell Counters, HCS Systems, Microarrays, Other Instruments, Single Cell Analysis, by Cell Type, Human Cells, Animal Cells, Microbial Cells)
By Technique: Based on technique, the market is segmented into Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques
By Application: Based on application, the market is segmented into Research Applications (Cancer, Immunology, Neurology, Stem Cell, Other Research Applications), Medical Applications (Noninvasive Prenatal Diagnosis, in Vitro Fertilization, Circulating Tumor Cell Detection)
By End User: Based on end user, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers, Academic & research laboratories have the largest share of this market by end user owing to rising number of medical colleges and increasing funding for research in life science.
By Region: North America owns the largest share of this market due to factors such as rising funding for research & development, high adoption for new technology and presence of key players of this market in North America.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Single Cell Analysis Market
4.4. Market Trends
5. Global Single Cell Analysis Market, By Product, 2019-2030 (USD Million)
5.1. Consumables
5.1.1. Beads
5.1.2. Microplates
5.1.3. Reagents
5.1.4. Assay Kits
5.1.4.1. Immunoassays
5.1.4.2. Cell-based Assays
5.1.5. Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
5.2. Instruments
5.2.1. Flow Cytometers
5.2.2. NGS Systems
5.2.3. PCR Instruments
5.2.4. Spectrophotometers
5.2.5. Microscopes
5.2.6. Cell Counters
5.2.7. HCS Systems
5.2.8. Microarrays
5.2.9. Other Instruments
5.2.10. Single Cell Analysis, by Cell Type
5.2.11. Human Cells
5.2.12. Animal Cells
5.2.13. Microbial Cells
6. Global Single Cell Analysis Market, By Technique, 2019-2030 (USD Million)
6.1. Flow Cytometry
6.2. Next-generation Sequencing
6.3. Polymerase Chain Reaction
6.4. Microscopy
6.5. Mass Spectrometry
6.6. Other Techniques
7. Global Single Cell Analysis Market, By Application, 2019-2030 (USD Million)
7.1. Research Applications
7.1.1. Cancer
7.1.2. Immunology
7.1.3. Neurology
7.1.4. Stem Cell
7.1.5. Other Research Applications
7.2. Medical Applications
7.2.1. Noninvasive Prenatal Diagnosis
7.2.2. in Vitro Fertilization
7.2.3. Circulating Tumor Cell Detection
8. Global Single Cell Analysis Market, By End User, 2019-2030 (USD Million)
8.1. Academic & Research Laboratories
8.2. Biotechnology & Pharmaceutical Companies
8.3. Hospitals & Diagnostic Laboratories
8.4. Cell Banks & IVF Centers
9. Global Single Cell Analysis Market, By Geography, 2019-2030 (USD Million)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America
9.4.2. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis, By Key Players
10.3. Competitive Scenario
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments
11. Company Profiles
11.1. 10x Genomics
11.2. Agilent Technologies, Inc.
11.3. Apogee Flow Systems Ltd.
11.4. Becton, Dickinson and Company
11.5. BioMérieux SA
11.6. Bio-Rad Laboratories
11.7. Corning Incorporated
11.8. Cytek Biosciences
11.9. Danaher Corporation
11.10. Fluidigm Corporation
11.11. Fluxion Biosciences
11.12. Illumina, Inc.
11.13. Luminex Corporation
11.14. Menarini Silicon Biosystems, Inc.
11.15. Merck KGAA
11.16. NanoCellect Biomedical
11.17. On-chip Biotechnologies Co., Ltd.
11.18. Oxford Nanopore Technologies
11.19. Promega Corporation
11.20. QIAGEN N.V.
11.21. Rarecyte Inc
11.22. Sartorius AG
11.23. Takara Bio
11.24. Tecan Group Ltd.
11.25. Thermo Fisher Scientific, Inc.
12. Appendix